Wilkinson Stekloff

United States (National)

Address:
2001 M Street, NW 10th Floor
Washington, DC 20036
United States (National)

Telephone:+1 202 847 4000
Fax:+1 202 847 4005
Email:

Contact us


In just over five years, Wilkinson Stekloff has established itself as the leading trial litigation boutique in the country, demonstrating a depth of talent and dexterity of skill unmatched by firms of any size. In its brief history, the firm has tried 17 cases to verdict, winning the vast majority of them. Over a single three-month span in 2019, WS handled three high-stakes, high-pressure trials in three different subject areas, with three different partners serving as lead trial counsel and eight different partners taking stand-up roles. This year, that intensity continues as the firm has tried two different high-profile cases while also serving as lead counsel in multiple high-profile antitrust and class action matters.

 

What makes Wilkinson Stekloff unique?

Our innovative business model allows us to deliver outstanding results, serve clients efficiently, and maintain our commitment to developing the next generation of trial lawyers. Clients welcome the certainty provided by Wilkinson Stekloff’s fixed fees, the quality of work ensured by our commitment to right-sized teams, and the exposure to a broad array of attorneys ready to do whatever it takes to achieve positive results.  


We know that cases are won by tight-knit teams of smart, innovative, and highly skilled litigators who share different perspectives but are united by a common commitment to excellence. So we have recruited the nation’s best and brightest young lawyers. Our attorneys come from the country’s premier large firms, DOJ, the White House, and federal clerkships, and include several former Supreme Court clerks. Our workforce reflects our ongoing commitment to diversity; Chambers has recognized Wilkinson Stekloff as a 2020 and 2021 “Outstanding Firm for Furthering Diversity and Inclusion.” Vault selected us as among the top five midsize law firms in the country for diversity and pro bono work.


Because we view it as critical not just to hire diverse attorneys but to give them meaningful trial experience and client exposure, the vast majority of our associates have already worked on at least one trial.  


Our clients have included heavy-hitters in a wide range of industries, such as Allergan, Altria Group Inc., Bayer, Facebook, FedEx, Georgia Pacific, Glenmark, Medtronic, Monsanto, the NCAA, the NFL, Pfizer, and Philip Morris USA — all of which have come to rely on Wilkinson Stekloff as a go-to trial firm that can handle their toughest cases. Our work during the last year shows the breadth and depth of our litigators’ talent and knowledge. 


Among many other matters, we represent Altria in an administrative proceeding before the FTC that was tried remotely in June, in three separate consolidated private antitrust cases pending in the Northern District of California, and in an MDL involving RICO and state-law claims in the same court. We are lead trial counsel for Monsanto in a trial in California state court involving claims that Roundup caused pediatric NHL. We are counsel for the NCAA in putative class action cases pending in district court involving the hotly debated issue of student-athlete names, images, and likenesses. We are the NFL’s lead lawyers in a broad-ranging antitrust challenge to its television broadcast agreements. 


And, showing that we can handle any type of litigation, anywhere, we successfully represented Judge Emmet Sullivan in mandamus proceedings in the U.S. Court of Appeals for the D.C. Circuit arising out of his handling of the high-profile criminal case involving former National Security Advisor Michael Flynn.


In addition to bet-the-company and other high-profile cases, we have handled almost 50 pro bono matters since our founding in 2016, with over 90% of the firm’s attorneys devoting significant time to those matters and the firm’s brightest young talent winning these trials in leadership roles. As a trial boutique, we pride ourselves on providing pro bono representation to clients facing trials, which can be particularly confusing or intimidating to individuals unfamiliar with the legal system. But the range of our pro bono litigation practice also covers appeals, class actions, and strategic counseling. In just the last year, our associates won precedent-setting appeals, obtained early release from prison for multiple individuals incarcerated as juveniles, and secured a landmark class action settlement that will provide life-saving hepatitis C drugs to people incarcerated in the Missouri Department of Corrections. Recognizing these efforts, Chambers & Partners recently gave us their “Highly Commended Pro Bono Program” award, recognizing us as having one of the two best pro bono programs out of all law firms nationwide.


We continue to receive accolades for our work across multiple areas of law. The National Law Journal named the firm as one of its Products Liability Groups of the Year and Law360 selected us as one of its Sports and Betting Practice Groups of the Year. Benchmark Litigation has twice named Wilkinson Stekloff the “Boutique Firm of the Year,” calling us a “litigator’s dream shop.” 


As we have continued to build our “dream team” of litigators, recruiting site Vault.com ranked us as one of the top three midsize law firms nationwide for compensation and selectivity. Our deep bench of go-to litigators includes Beth Wilkinson, recently named a national Star Trial Lawyer by Chambers; Brian Stekloff, ranked by Chambers as a nationally prominent products liability trial lawyer; James Rosenthal, noted as a “Winning Litigator” by the National Law Journal; Kosta Stojilkovic and Moira Penza, designated as “Rising Stars” for trials by Law360, Rakesh Kilaru, recognized as a “Rising Star” for sports and betting by Law360; and Kieran Gostin, honored as a “Rising Star” by the National Law Journal.


These accomplishments underscore Wilkinson Stekloff’s reputation as a litigation juggernaut. Lawyer for lawyer and matter for matter, we simply outperform our competition.

 

Updated Sep 2021